Your browser doesn't support javascript.
Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia.
Fernando, Emmaline Zantua; Yu, Jeryl Ritzi Tan; Santos, Salvador Miclat Abad; Jamora, Roland Dominic Go.
  • Fernando EZ; Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines.
  • Yu JRT; Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines.
  • Santos SMA; Infection Control Service and Department of Internal Medicine, St. Luke's Medical Center, Global City, Philippines.
  • Jamora RDG; Institute for Neurosciences, St. Luke's Medical Center, Quezon City, Philippines.
J Mov Disord ; 14(1): 75-77, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-961921
ABSTRACT
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia. He was referred for evaluation of myoclonus of all extremities, which resolved after discontinuation of HCQ. The involuntary movements were first reported after the initiation of HCQ, persisted despite improvement in inflammatory and radiologic parameters and eventually resolved after HCQ discontinuation. This supports a possible causality related to adverse drug reactions from HCQ that have not been commonly reported.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Experimental Studies Language: English Journal: J Mov Disord Year: 2021 Document Type: Article Affiliation country: Jmd.20091

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Experimental Studies Language: English Journal: J Mov Disord Year: 2021 Document Type: Article Affiliation country: Jmd.20091